No insider purchase over the last 90 days. The latest, by PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., was filed 12 May 2023.
Performant Financial Corp is a Business Services company. Its directors and officers file their transactions with SEC (Form 4). Performant Financial Corp has had no insider filing for more than a year; the last one goes back to 22 October 2025.
Looking back to 2016, when coverage begins, insiders filed 48 purchases and 72 sales.
Other companies in the same sector with recent insider buying flagged by our signals: ELIS and GL Events. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2024 · cache
25 of 391 declarations
Performant Financial Corp. (ticker PFMT) was listed on the NASDAQ market in the United States and operated as a technology-enabled services company focused on healthcare payment integrity and related analytics. In practical terms, Performant helped payers identify, prevent, and recover waste, improper payments, and other reimbursement errors by combining proprietary data assets, analytics, and workflow technology. The company’s filings describe it as operating with a single reporting segment, which underscores a relatively focused business model centered on healthcare payer solutions rather than a diversified multi-vertical platform. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1550695/000155069524000098/pfmt-20240930.htm?utm_source=openai))
Historically, Performant is a Delaware corporation formed in 2003, but its operating roots go back much further through PRI, its core subsidiary, which was founded in 1976. That long operating heritage matters because it suggests deep experience in audit, recovery, and compliance-intensive services. For headquarters, the most recent SEC filings state that Performant’s Plantation, Florida facility served as corporate headquarters; earlier materials had referenced Livermore, California, which indicates the company’s headquarters footprint changed over time. For investors, the key takeaway is that by 2024–2025 the corporate base was in Florida. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1550695/000155069525000008/pfmt-20241231.htm?utm_source=openai))
Performant’s core offering sat at the intersection of healthcare services, analytics, and recoveries. The company supported payers in spotting billing anomalies, validating eligibility, and recovering overpayments using advanced technology and proprietary data. Its competitive position was built less on capital intensity and more on domain expertise, data-driven models, and the ability to navigate a complex reimbursement environment. In a market like U.S. healthcare payment integrity, the moat typically comes from know-how, implementation capability, client relationships, and compliance execution. Performant’s disclosures also highlight that its business was concentrated in the United States, with healthcare payers as the principal customer base. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1550695/000155069525000008/R24.htm?utm_source=openai))
As a listed company on NASDAQ in the United States, PFMT’s more recent corporate story was dominated by M&A rather than organic expansion. On July 31, 2025, Performant entered into a definitive merger agreement with Machinify, a healthcare intelligence company backed by New Mountain Capital. The company announced that stockholders would receive $7.75 in cash per share, and the transaction was later approved by stockholders at a special meeting on October 17, 2025. The merger closed on October 21, 2025, meaning Performant ceased to be an independent public equity story after that date. For a market overview, that is the most important recent development: the company moved from public-market operating asset to acquired healthcare technology platform. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1550695/000155069525000061/exhibit9911.htm?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2024 | 123.0 m USD | -9.9 m USD | -0.13 USD | 10-K |
| Dec 2023 | 113.7 m USD | -7.5 m USD | -0.10 USD | 10-K |
| Dec 2022 | 109.2 m USD | -6.5 m USD | -0.09 USD | 10-K |
| Dec 2021 | 124.4 m USD | -10.3 m USD | -0.17 USD | 10-K |
| Dec 2020 | 155.9 m USD | -14.0 m USD | -0.26 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.